title: Proteomic identification of potential susceptibility factors in drug-induced liver disease.
abstract: Drug-induced liver disease (DILD) causes significant morbidity and mortality and impairs new drug development. Currently, no known criteria can predict whether a drug will cause DILD or what risk factors make an individual susceptible. Although it has been shown in mouse studies that the disruption of key regulatory factors, such as cyclooxygenase-2 (COX-2), interleukin (IL)-6, and IL-10, increased susceptibility to DILD caused by acetaminophen (APAP), no single factor seems to be absolute. As an approach to better understand the multifactorial basis of DILD, we compared the hepatic proteome of mice that are resistant (SJL) and susceptible (C57Bl/6) to APAP-induced liver disease (AILD), using solution-based isotope-coded affinity tag (ICAT) liquid chromatography mass spectrometry. Several novel factors were identified that were more highly expressed in the livers of SJL mice, including those involved in stress response, cell proliferation and tissue regeneration, and protein modification, implicating these proteins as potential hepatoprotective factors. There was also a selective loss of several mitochondrial proteins from the livers of the susceptible C57Bl/6 mice, suggesting that the loss of functional mitochondria may indeed play a role in AILD. These findings indicate that comparative hepatic proteomic analyses of susceptible and resistant mouse strains may provide a global approach for identifying potential risk factors and mechanistic pathways responsible for DILD.
authors.affiliation: Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. WelchKD@nhlbi.nih.gov
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Welch
authors.forename: Bo
authors.initials: B
authors.lastname: Wen
authors.forename: David R
authors.initials: DR
authors.lastname: Goodlett
authors.forename: Eugene C
authors.initials: EC
authors.lastname: Yi
authors.forename: Hookeun
authors.initials: H
authors.lastname: Lee
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Reilly
authors.forename: Sidney D
authors.initials: SD
authors.lastname: Nelson
authors.forename: Lance R
authors.initials: LR
authors.lastname: Pohl
mesh_terms: D000082:Acetaminophen / Q000633:toxicity; D000345:Affinity Labels / Q000737:chemistry; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D002846:Chromatography, Affinity; D004198:Disease Susceptibility / Q000378:metabolism; D004351:Drug Resistance; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008107:Liver Diseases / Q000378:metabolism / Q000401:mortality; D008297:Male; D013058:Mass Spectrometry; D051379:Mice; D008810:Mice, Inbred C57BL; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D013045:Species Specificity
chemical_list: D000345:Affinity Labels; D000082:Acetaminophen